BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8129813)

  • 1. Clinical implication of microdialysis findings.
    Deakin JF; Graeff FG; Guimaraes FS
    Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA; Li P
    J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT and antidepressants: new views from microdialysis studies.
    Artigas F
    Trends Pharmacol Sci; 1993 Jul; 14(7):262. PubMed ID: 8212321
    [No Abstract]   [Full Text] [Related]  

  • 4. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
    Artigas F
    Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-HT and antidepressants: in vitro and in vivo release studies.
    Briley M; Moret C
    Trends Pharmacol Sci; 1993 Nov; 14(11):396-7. PubMed ID: 8296396
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychobiology and psychopharmacotherapy of unipolar major depression: a review.
    O'Toole SM; Johnson DA
    Arch Psychiatr Nurs; 1997 Dec; 11(6):304-13. PubMed ID: 9419922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical effects of antidepressant augmentation.
    Howland RH
    Arch Gen Psychiatry; 1995 Feb; 52(2):156. PubMed ID: 7848052
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the treatment of depression, does selectivity of action matter?
    J Clin Psychiatry; 2004; 65 Suppl 4():60-2. PubMed ID: 15046543
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function.
    Dale E; Pehrson AL; Jeyarajah T; Li Y; Leiser SC; Smagin G; Olsen CK; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):143-61. PubMed ID: 26346726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the serotonin system in the treatment of major depressive disorder.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in choosing an antidepressant.
    Kingsbury SJ; Simpson GM
    Psychiatr Serv; 2001 Nov; 52(11):1435-6. PubMed ID: 11684736
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin: current understanding and the way forward.
    Dinan TG
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():19-21. PubMed ID: 8732440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors pathway.
    Sangkuhl K; Klein TE; Altman RB
    Pharmacogenet Genomics; 2009 Nov; 19(11):907-9. PubMed ID: 19741567
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical alterations of serotonergic neuronal systems in depression.
    Risch SC; Nemeroff CB
    J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.